Details for New Drug Application (NDA): 085015
✉ Email this page to a colleague
NDA 085015 describes TRIMEPRAZINE TARTRATE, which is a drug marketed by Alpharma Us Pharms and Morton Grove and is included in two NDAs. Additional details are available on the TRIMEPRAZINE TARTRATE profile page.
The generic ingredient in TRIMEPRAZINE TARTRATE is trimeprazine tartrate. There are five drug master file entries for this compound. Additional details are available on the trimeprazine tartrate profile page.
The generic ingredient in TRIMEPRAZINE TARTRATE is trimeprazine tartrate. There are five drug master file entries for this compound. Additional details are available on the trimeprazine tartrate profile page.
Summary for 085015
| Tradename: | TRIMEPRAZINE TARTRATE |
| Applicant: | Alpharma Us Pharms |
| Ingredient: | trimeprazine tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085015
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | EQ 2.5MG BASE/5ML | ||||
| Approval Date: | Feb 18, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
